Characterization of the optimal stimulatory effects of graves' monoclonal and serum immunoglobulin G on adenosine 3',5'-monophosphate production in fRTL-5 thyroid cells: a potential clinical assay.
about
Bioassays for TSH Receptor Autoantibodies, from FRTL-5 Cells to TSH Receptor-LH/CG Receptor Chimeras: The Contribution of Leonard D. KohnStudies on multiple thyroid cell membrane-directed antibodies in Graves' disease.Clinical applications of assays for thyrotropin-receptor antibodies in Graves' disease.Molecular basis for the autoreactivity against thyroid stimulating hormone receptor.Kappa/lambda immunoglobulin distribution in Graves' thyroid-stimulating antibodies. Simultaneous analysis of C lambda gene polymorphisms.The microsomal/peroxidase antigen: modulation of its expression in thyroid cells.Thyrotropin upregulates alpha 1-adrenergic receptors in rat FRTL-5 thyroid cells.Novel chimeric thyroid-stimulating hormone-receptor bioassay for thyroid-stimulating immunoglobulins.Autoimmune thyroid disease: immunological, pathological, and clinical aspects.A new chemiluminescent assay for the rapid detection of thyroid stimulating antibodies in Graves' disease.Transfection with the cDNA of the human thyrotropin receptor of a poorly differentiated rat thyroid cell line (FRT).Detection of antibodies blocking thyrotropin effect using Chinese hamster ovary cells transfected with the cloned human TSH receptor.Concurrent overexpression of RET/PTC1 and TTF1 confers tumorigenicity to thyrocytes.Intrathyroidal lymphocytes from non toxic multinodular goiter: no evidence for production of thyroid stimulating antibodies.Thyroid growth stimulating activity in highly purified IgG-fractions of patients with nonimmune thyroid diseases.Detection and characterization of autoantibodies blocking the TSH-dependent cAMP production using FRTL-5 cells.Recombinant gamma-interferon stimulates iodide uptake and cyclic AMP production by the FTRL5 thyroid cell line.
P2860
Q26738446-0C86DD7D-8B01-4615-8B3A-9D9E897BB395Q34564898-C1F2F053-D3CB-4C74-9716-B88CBA6F259CQ34728141-E0F75669-381F-42B4-8835-16E9940F95DDQ35165155-9B4314E3-1C7C-4994-9EC2-62FD1E06F854Q35591528-012A32DA-330A-46B2-BA45-A41C97BDC977Q36457951-7EEE3B65-B3C2-48B3-9E0A-EFD57759FB1BQ37558484-C2EF109A-73E5-4BB1-AB9B-CE7CED5B1E6AQ39633110-E76823CB-1B12-40B5-93A0-7E980758E22EQ39641913-7C182446-148C-4639-AC73-265134B25F17Q40961822-E823ABB8-D201-4D85-B5CB-CE43D72F8716Q41207603-64340483-F38E-406A-A02A-F6CD50F71EC7Q41433781-71A77D04-AA31-4A51-A531-6E708C02C42CQ41822268-B439F72E-1C36-4F3A-BF91-54690BAABB79Q42475228-4541565F-55F2-4890-AC3A-DB3480CA99CDQ42495014-9875C171-D813-4FF1-85F5-E3918F42E46EQ44214972-072C7E5E-89F7-42FF-B002-8903918B07F5Q44471171-F9510AE5-800B-440F-9143-29B2FEF3A70B
P2860
Characterization of the optimal stimulatory effects of graves' monoclonal and serum immunoglobulin G on adenosine 3',5'-monophosphate production in fRTL-5 thyroid cells: a potential clinical assay.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年学术文章
@wuu
1983年学术文章
@zh
1983年学术文章
@zh-cn
1983年学术文章
@zh-hans
1983年学术文章
@zh-my
1983年学术文章
@zh-sg
1983年學術文章
@yue
1983年學術文章
@zh-hant
name
Characterization of the optima ...... s: a potential clinical assay.
@en
Characterization of the optima ...... s: a potential clinical assay.
@nl
type
label
Characterization of the optima ...... s: a potential clinical assay.
@en
Characterization of the optima ...... s: a potential clinical assay.
@nl
prefLabel
Characterization of the optima ...... s: a potential clinical assay.
@en
Characterization of the optima ...... s: a potential clinical assay.
@nl
P2093
P356
P1476
Characterization of the optima ...... s: a potential clinical assay.
@en
P2093
Ambesi-Impiombato FS
Grollman EF
Laccetti P
Pinchera A
Rotella CM
Toccafondi R
Valente WA
P304
P356
10.1210/JCEM-57-4-782
P407
P577
1983-10-01T00:00:00Z